ATE313T1 - Antigenpraeparat verwendbar fuer vakzine oder als zwischenprodukt dafuer und verfahren zu seiner herstellung. - Google Patents

Antigenpraeparat verwendbar fuer vakzine oder als zwischenprodukt dafuer und verfahren zu seiner herstellung.

Info

Publication number
ATE313T1
ATE313T1 AT79101777T AT79101777T ATE313T1 AT E313 T1 ATE313 T1 AT E313T1 AT 79101777 T AT79101777 T AT 79101777T AT 79101777 T AT79101777 T AT 79101777T AT E313 T1 ATE313 T1 AT E313T1
Authority
AT
Austria
Prior art keywords
vaccine
thereor
manufacture
antigen preparation
preparation usable
Prior art date
Application number
AT79101777T
Other languages
English (en)
Inventor
Alfred Mayer Prince
John Andrew Vnek
Original Assignee
New York Blood Center, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Center, Inc. filed Critical New York Blood Center, Inc.
Application granted granted Critical
Publication of ATE313T1 publication Critical patent/ATE313T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10161—Methods of inactivation or attenuation
    • C12N2730/10162—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT79101777T 1978-06-07 1979-06-06 Antigenpraeparat verwendbar fuer vakzine oder als zwischenprodukt dafuer und verfahren zu seiner herstellung. ATE313T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91342278A 1978-06-07 1978-06-07
EP79101777A EP0005864B1 (de) 1978-06-07 1979-06-06 Antigenpräparat verwendbar für Vakzine oder als Zwischenprodukt dafür und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ATE313T1 true ATE313T1 (de) 1981-11-15

Family

ID=25433258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79101777T ATE313T1 (de) 1978-06-07 1979-06-06 Antigenpraeparat verwendbar fuer vakzine oder als zwischenprodukt dafuer und verfahren zu seiner herstellung.

Country Status (8)

Country Link
EP (1) EP0005864B1 (de)
JP (1) JPS54160716A (de)
AT (1) ATE313T1 (de)
AU (1) AU530195B2 (de)
CA (1) CA1117010A (de)
DE (1) DE2961060D1 (de)
MX (1) MX6290E (de)
ZA (1) ZA792485B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド Ｂ型肝炎ワクチン製造方法
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
WO1985004103A1 (en) * 1984-03-09 1985-09-26 Scripps Clinic And Research Foundation Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
FI932248A7 (fi) * 1991-09-18 1993-07-02 Amgen Inc Sappihapposuolaa sisältävä hepatiitti B-rokotekoostumus
CA3080656A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1012445B (it) * 1973-05-21 1977-03-10 Siderurgie Fse Inst Rech Procedimento per la dissulfurazione dei metalli fusi
JPS5714653B2 (de) * 1974-06-21 1982-03-25
SE437329B (sv) * 1975-03-14 1985-02-25 Community Blood Council Sett att ur blodserum framstella vaccin mot virushepatit
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
GB1518582A (en) * 1975-11-17 1978-07-19 Community Blood Council Viral hepatitis vaccine
JPS53104724A (en) * 1977-02-23 1978-09-12 Green Cross Corp:The Preparation of uniform hbsag particles

Also Published As

Publication number Publication date
ZA792485B (en) 1980-06-25
EP0005864B1 (de) 1981-10-21
AU4767179A (en) 1979-12-13
CA1117010A (en) 1982-01-26
MX6290E (es) 1985-03-18
EP0005864A1 (de) 1979-12-12
DE2961060D1 (en) 1981-12-24
JPS54160716A (en) 1979-12-19
AU530195B2 (en) 1983-07-07

Similar Documents

Publication Publication Date Title
DE69031556D1 (de) Antigene sowie Verfahren zu deren Herstellung
GB2070621B (en) Nucleotidic sequence coding the surface antigen of the hepatitis b virus vector containing said nucleotidic sequence process allowing the obtention thereof and antigen obtained thereby
AT370427B (de) Verfahren zur herstellung von submikroskopischen teilchen
ATE313T1 (de) Antigenpraeparat verwendbar fuer vakzine oder als zwischenprodukt dafuer und verfahren zu seiner herstellung.
IE780716L (en) Hepatitis b core antigens.
ATA980275A (de) Verfahren zur herstellung eines schuetzenden antigens von bordetella pertussis
BE838474A (fr) Detection de l'antigene de surface de l'hepatite b par agglutination de latex
ATA75980A (de) Verfahren zur herstellung von in spruehgetrocknetenreinigungsmitteln verwendbaren zeolith-alkyl- benzolsulfonat-zusammensetzungen mit hohem feststoffgehalt
DE69130724D1 (de) Verfahren zur Gewinnung von rekombinantem Hepatitis B Virus (HEP B) Oberflächeantigen
EP0339668A3 (de) Hepatitis-A-Virus aufgebautes Antigen
ATE4282T1 (de) Verfahren zur herstellung von toxoplasmenbereitungen fuer die toxoplasmosediagnose und die so hergestellten bereitungen.
JPS5692219A (en) Purification of biologically original particle* particularly antigen *aghbs* of b type hepatitis virus surface
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
FR2464269B1 (fr) Sequence nucleotidique codant l'antigene de surface du virus de l'hepatite b, procede permettant son obtention et antigene obtenu
PT87001A (pt) Processo para a preparacao de uma vacina contra a disenteria suina e fins analogos
Černá et al. CONTRIBUTION TO THE SER O LOGICAL, DIA (; NO S IS OF SARCO CYSTO SIS
JPS5244229A (en) Method of making serological reagent for syphilis
IT7849082A0 (it) Antigene di superficie dell'epatite b
JPS5344620A (en) Recovering of immobilized vaccine and specific antigen
GB1518582A (en) Viral hepatitis vaccine
Evseeva et al. ELISA: Preparation and characteristics of Soviet reagents for detection of hepatitis B virus surface antigen in blood sera.
XU EVALUATION OF DIAGNOSTIC SIGNIFICANCE OF ANTI-HBc IgM IN SUBCLINICAL HEPATITIS B INFECTION
JPS5644850A (en) Serological early stage diagnosis of a-type acute hepatitis
ATA219889A (de) Komplex geeignet zur durchfuehrung eines verfahrens zur reinigung von pre-s-hepatitis-bvirus-oberfl|chenantigen
Berezin et al. Study of binding of hepatitis B virus surface antigen with antibody after various denaturating treatments and different methods of analysis.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee